Latest Funding Strategy News

Tungsten Mining NL's Watershed Preliminary Economic Evaluation reveals a robust project with a pre-tax NPV of A$1.3 billion and a swift payback, aiming for first production by 2027 amid tightening global tungsten supply.

Pure Resources has demonstrated that its Carbon Nanotube Fibre matches copper’s thermal conductivity while weighing up to 5.5 times less, positioning it as a breakthrough for weight-sensitive thermal management in AI and defence sectors.

Commonwealth Bank of Australia has announced fully franked quarterly distributions ranging from AUD 1.2733 to AUD 1.3174 on four series of its PERLS capital notes, payable in September 2026.

Charter Hall Social Infrastructure REIT (CQE) has acquired a 25% interest in a $53 million Brisbane pathology lab leased to Sonic Healthcare under a 20-year triple-net lease, while divesting early learning assets and reaffirming FY26 guidance.

Aurum Resources has unveiled a robust Pre-Feasibility Study for its Boundiali Gold Project in Côte d'Ivoire, declaring a maiden Probable Ore Reserve of 1.21 million ounces and targeting first gold production in early 2028.

Aura Energy has secured a strategic non-binding MOU with a major international nuclear utility, underpinning funding and technical collaboration for its Tiris Uranium Project in Mauritania. The company has locked in a robust processing flowsheet and aims for a Final Investment Decision by the end of 2026.

Corporate Travel Management reports progress on UK customer remediation with funding plans underway and final agreements near completion. The company maintains strong client retention above 97% and aims to release audited FY25 and reviewed 1H26 financials by end of June, eyeing a swift return to ASX trading.

Green Technology Metals (ASX: GT1) secured $1.87 million from its recent entitlement offer, with underwriters stepping in to cover a $2.13 million shortfall. The capital raise supports ongoing development of its Ontario lithium project.

Hawk Resources has dispatched materials for a $1.97 million non-renounceable entitlement offer priced at 3 cents per share, offering shareholders free options and a chance to apply for shortfall shares.

Delorean Corporation has closed its Share Purchase Plan, raising $750,000 through the issue of over 8.3 million shares at $0.09 each, supplementing earlier strategic funding from LMS Energy.

Australian Oil Company Limited is raising $250,000 through a Share Purchase Plan priced at $0.0029 per share, including free-attaching options exercisable by mid-2028. The capital will support oil production enhancements and exploration in Queensland's Surat Basin.

Island Pharmaceuticals has appointed Raymond Taylor, a former BioCryst executive with deep Galidesivir expertise and US government funding experience, to accelerate development and procurement efforts for its broad-spectrum antiviral amid rising viral threats.